Genolution Inc. (225220) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of Genolution Inc. stock KRW 1,703, price KRW 1,744, that is 2.4% below the price, quality 42 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Genolution Inc.
225220 · KQThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range 1,030 KRW – 9,205 KRW · fair‑value band 1,277 KRW – 2,129 KRW · the 1,744 KRW price screens above the 1,703 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Genolution is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology.
Show moreShow less
The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits.
It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/shRNA synthesis service and related products. Genolution Inc. was founded in 2006 and is based in Seoul, South Korea.
Stock analysis
Genolution Inc. (225220) currently trades at 1,744 KRW, while our estimate is 1,703 KRW, so the stock looks roughly fairly valued today (gap 2.5%).
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 1,277 KRW (bear) to 2,129 KRW (bull), the price of 1,744 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Genolution Inc. reported revenue of 9.4B KRW in FY2025 versus 72.8B KRW in FY2021, a compound −40.1%/yr. Reported net income was −11.6B KRW in FY2025.
Key figures
Market cap 31.5B KRW (≈ $23.7M) Micro · P/S ratio 3.10 · EPS (TTM) −257.81 KRW · Net margin −46.5% · Return on equity −7.9% · Return on assets (EBIT) 6.3% (5-year average) · Operating margin −51.6% · Revenue (TTM) 10.0B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 17% below its 52-week high and 69% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −2%, 225220 screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch 225220, get fair value alerts →
Compare Genolution Inc. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 851 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- PEG screener for stocks with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $945.53 | $1,275 | +35% | vs 225220 |
| Vertex Pharmaceuticals Incorporated VRTX | $536.45 | $587.62 | +10% | vs 225220 |
| Samsung Biologics Co 207940 | 1,375,000 KRW | 1,502,600 KRW | +9% | vs 225220 |
| argenx SE ARGX | $941.25 | $908.40 | −3% | vs 225220 |
| CSL Limited CSL | A$199.85 | A$186.49 | −7% | vs 225220 |
| Moderna, Inc MRNA | $196.79 | $135.64 | −31% | vs 225220 |
| BeOne Medicines AG 6160 | HK$242.60 | HK$152.92 | −37% | vs 225220 |
| Revolution Medicines, Inc RVMD | $159.82 | $83.12 | −48% | vs 225220 |
| Celltrion, Inc 068270 | 215,000 KRW | 74,945 KRW | −65% | vs 225220 |
| Royalty Pharma plc RPRX | $68.67 | $19.01 | −72% | vs 225220 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Genolution Inc. (225220) overvalued or undervalued?
What is the fair value of 225220?
What is the quality score of 225220?
What is the price target for Genolution Inc. (225220)?
What is the Genolution Inc. stock forecast for 2026?
What is the revenue of Genolution Inc. (225220)?
What is the intrinsic value of Genolution Inc. (225220)?
Is Genolution Inc. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 225220?
How much is Genolution Inc. worth?
What do the bullish and bearish scenarios say about 225220?
How solid is the balance sheet of Genolution Inc. (225220)?
How far is 225220 from its 52-week high?
Which stocks are comparable to Genolution Inc.?
Is Genolution Inc. stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Genolution Inc. (225220)?
What should I pay attention to with Genolution Inc. right now?
Key figures of Genolution Inc.
How large is the market capitalisation of Genolution Inc. (225220)?
What is the P/S ratio of Genolution Inc. (225220)?
What are the earnings per share of Genolution Inc. (225220)?
What is the net margin of Genolution Inc. (225220)?
What is the return on equity of Genolution Inc. (225220)?
What is the EBIT return on assets of Genolution Inc. (225220)?
What is the operating margin of Genolution Inc. (225220)?
How fast is revenue growing at Genolution Inc. (225220)?
How much free cash flow does Genolution Inc. (225220) generate?
How much net debt does Genolution Inc. (225220) carry?
Watch Genolution Inc. in the live analysis
One click puts Genolution Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.